C D Hillyer

Association of busulfan area under the curve with veno-occlusive disease following BMT.

S P Dix, John R. Wingard, Richard E. Mullins et al. · PubMed · 1996 · 323 citations

Medicine, Hematology, Hematopathology +3

Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.

H. Kent Holland, S P Dix, Robert B. Geller et al. · Journal of Clinical Oncology · 1996 · 50 citations

Medicine, Oncology, Breast Oncology +16

Effect of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on hematopoietic regeneration as demonstrated in a nonhuman primate chemotherapy model

EF Winton, Jayanthi Srinivasiah, BK Kim et al. · Blood · 1994 · 41 citations · Full text

Life Sciences, Hematology, Immunology +13

The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.

Steve Devine, RB Geller, Liming Lin et al. · PubMed · 1997 · 35 citations

Pharmacy, Hematology, Immunology +14

Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation

RB Geller, SM Devine, Kevin S. O’Toole et al. · Bone Marrow Transplantation · 1997 · 16 citations · Full text

Medicine, Hematology, Oncology +16